Deep Tech Startups

Nano PharmaSolutions develops NanoTransformer, a patented nanodrug manufacturing platform that improves drug solubility and bioavailability, and delivery systems such as Nano-CNS for neurotherapeutics via nasal spray. The company applies its technology to drug-device combination products for the pharmaceutical industry.

2 investors

NanoPhoria is a life sciences company that raised an €83.5 million Series A round. The page focuses on its investors and does not detail its specific product or technology.

2 investors

nanoSkunkWorkX develops nanostructured Scalable Devices (nSDs) — embedded interface devices made from bulk graphene that control heat, charge, energy, and signal flow at system interfaces. The company focuses on turning raw graphene into manufacturable hardware through materials engineering.

2 investors

NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.

2 investors

Nano-Tex develops textile treatment technologies applied to fabrics for properties such as water repellency, stain resistance, moisture wicking, wrinkle resistance, and UV protection. It offers branded finishes (e.g. Aquapel, Dry Inside, Wick+Block) and related product materials like hangtags for apparel and textile manufacturers.

2 investors

Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader. The platform serves biotechnology research and therapeutic analysis workflows.

2 investors

The NATO Innovation Fund is a standalone venture capital fund backed by 24 NATO allies, deploying over €1 billion into deep tech startups. It invests in founders working on defence, security, and resilience challenges, including infrastructure protection, the climate and energy transition, and resilient supply chains.

2 investors

Nature Architects develops computational design technology rooted in metamaterials and origami engineering to find shapes that control physical phenomena, combining proprietary design methods and software to enable new designs. It works alongside manufacturing clients to solve difficult design challenges and develop design processes.

2 investors

NAVAN develops a non-perturbative intracellular delivery technology that transports a wide range of cargo types into primary cell types while preserving cell viability and function. The company applies this platform to cell and gene therapy development across multiple indications through strategic partnerships.

2 investors

Navier provides cloud-based engineering agents that automate simulation setup and workflows for hardware engineers in aerospace and defense, enabling faster design iterations without manual configuration overhead.

2 investors

NavVis builds reality capture hardware (the LX-Series wearable/handheld SLAM scanners) and reality access software (NavVis IVION) that processes scan data into survey-grade point clouds, panoramic images, and browser-accessible digital twins. Its tools serve surveying, construction, and industrial teams creating digital twins of physical spaces and assets.

2 investors

NDotLight develops AI-powered 3D CAD design automation and simulation-ready data generation tools for manufacturers. The platform uses text and image inputs to automatically generate precise 3D CAD models and physics-enabled digital twins, targeting manufacturing companies seeking to digitalize production workflows.

2 investors

Nectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.

2 investors

Neo is a blockchain platform for building decentralized applications and smart contracts, offering developer tooling and support for writing contracts in multiple languages including Python, C#, Go, TypeScript, and Java. It provides standards such as NEP-17 tokens for developers building on its network.

2 investors

NeoEarth develops performance improvements for industrial microalgae strains, combining microalgae biology research with cultivation and production process development. It works to scale industrial collaborations and partnerships around microalgae engineering.

2 investors

Neobe Therapeutics is developing a synthetic biology platform to engineer programmable live biotherapeutic products—microbial "trojan horses"—that disrupt the microenvironment of solid tumours. The company aims to enable immunotherapy to work in patients with immune-excluded tumours, operating in cancer therapeutics.

2 investors

NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair. It maintains a drug pipeline and operates as a publicly traded company.

2 investors

Neuraworx Medical Technologies is a medical device company developing Intelligent Cerebrovascular Pacing, a bioelectronic technology intended to enhance the brain's glymphatic system function and cerebral fluid clearance. The technology targets brain health by improving removal of extracellular biomolecular debris associated with aging and disease.

2 investors

Neuroharmonics is developing a non-invasive neuromodulation platform based on focused transcranial ultrasound to modulate specific brain circuits for treating neurological and psychiatric conditions and enabling brain-computer interaction. The company operates in the neurotech and medical technology space.

2 investors

Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.

2 investors

NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.

2 investors

NewPhotonics designs highly integrated silicon photonic integrated circuit (PIC) chips and all-optical signal processing technology for optical transceivers, pluggables, and co-packaged optics. Its products target energy- and bandwidth-efficient optical connectivity in AI-scale data center infrastructure.

2 investors

NexMR, an ETH Zurich spin-off, develops light-coupled NMR hardware, consumables, and automated analysis software to increase throughput and reduce resource use in NMR-based drug discovery pipelines. Its sensitivity-enhanced technology targets early-stage drug discovery workflows, including hit affinity determination and screening of challenging targets.

2 investors

NextInput builds silicon-based MEMS force-sensing technology and turnkey human-machine interface (HMI) solutions, spanning hardware and software, for a range of applications including mobile phones. The company provides sensing components to device makers and was acquired by Qorvo, Inc. in 2021.

2 investors